Researchers hope that generative AI — neural networks that can create text, images and other content on the basis of learnt patterns — will speed up development and help to unlock antibody drugs for targets that have resisted conventional design approaches.

研究人员希望，生成式人工智能——可以在学习模式的基础上创建文本、图像和其他内容的神经网络——将加速开发，并帮助开发抗体药物，用以针对传统设计方法无法实现的目标。